1. Home
  2. DRVN vs SYRE Comparison

DRVN vs SYRE Comparison

Compare DRVN & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$10.34

Market Cap

2.8B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$39.85

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
SYRE
Founded
1972
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
DRVN
SYRE
Price
$10.34
$39.85
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$19.57
$55.57
AVG Volume (30 Days)
2.3M
693.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
0.69
N/A
Revenue
$2,339,588,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.10
N/A
P/E Ratio
$15.25
N/A
Revenue Growth
1.54
N/A
52 Week Low
$9.80
$10.91
52 Week High
$19.74
$45.76

Technical Indicators

Market Signals
Indicator
DRVN
SYRE
Relative Strength Index (RSI) 21.20 54.58
Support Level $9.80 $38.36
Resistance Level $15.91 $45.76
Average True Range (ATR) 0.59 1.93
MACD -0.19 -0.43
Stochastic Oscillator 7.29 28.37

Price Performance

Historical Comparison
DRVN
SYRE

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: